NEK2 is a potential pan-cancer biomarker and immunotherapy target
NEK2 may be a potential pan-cancer biomarker and immunotherapeutic target for improving the efficacy of tumor therapy.
Authors
- Lanyue Zhang (ORCID: https://orcid.org/0000-0002-5153-5473)
- Tingting Liu (ORCID: https://orcid.org/0000-0001-9623-7114)
- Fujin Shen
- Juexiao Deng
- Wenxin Liao
- Yang Li (ORCID: https://orcid.org/0000-0002-6227-5160)
Institutions
- Wuhan University (CN)
- Renmin Hospital of Wuhan University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1007/s12672-024-01519-7
- Citations
- 3
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province